Financial Assets and Liabilities (Tables)
|
9 Months Ended |
Jul. 31, 2020 |
Financial Assets And Liabilities [Abstract] |
|
Summary of Cash Equivalents |
As of July 31, 2020, the balances of the Company’s cash equivalents were: | | | | | | | | | | | | | | | | | | | | | | Cost | | Gross Unrealized Gains | | Gross Unrealized Losses Less Than 12 Continuous Months | | Gross Unrealized Losses 12 Continuous Months or Longer | | Estimated Fair Value(1) | | (in thousands) | Cash equivalents: | | | | | | | | | | Money market funds | $ | 280,417 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 280,417 |
| Total: | $ | 280,417 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 280,417 |
|
| | (1) | See Note 7. Fair Value Measures for further discussion on fair values of cash equivalents. |
As of October 31, 2019, the balances of the Company’s cash equivalents were: | | | | | | | | | | | | | | | | | | | | | | Cost | | Gross Unrealized Gains | | Gross Unrealized Losses Less Than 12 Continuous Months | | Gross Unrealized Losses 12 Continuous Months or Longer | | Estimated Fair Value(1) | | (in thousands) | Cash equivalents: | | | | | | | | | | Money market funds | $ | 166,024 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 166,024 |
| Total: | $ | 166,024 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 166,024 |
|
(1) See Note 7. Fair Value Measures for further discussion on fair values of cash equivalents.
|
Schedule of Cash, Cash Equivalents and Restricted Cash |
The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets: | | | | | | | | | | As of | | July 31, 2020 | | October 31, 2019 | | (in thousands) | Cash and cash equivalents | $ | 1,049,922 |
| | $ | 728,597 |
| Restricted cash included in Prepaid expenses and other current assets | 1,287 |
| | 1,174 |
| Restricted cash included in Other long-term assets | 779 |
| | 756 |
| Total cash, cash equivalents and restricted cash | $ | 1,051,988 |
| | $ | 730,527 |
|
|
Effects on Changes in Fair Values of Non-Designated Forward Contracts |
The effects of the non-designated derivative instruments on the Company’s unaudited condensed consolidated statements of operations is summarized as follows: | | | | | | | | | | | | | | | | | | Three Months Ended July 31, | | Nine Months Ended July 31, | | 2020 | | 2019 | | 2020 | | 2019 | | (in thousands) | Gain (loss) recorded in other income (expense), net | $ | 2,995 |
| | $ | 1,179 |
| | $ | 1,891 |
| | $ | 4,314 |
|
|
Notional Amounts of Derivative Instruments |
The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding: | | | | | | | | | | As of | | July 31, 2020 | | October 31, 2019 | | (in thousands) | Total gross notional amount | $ | 838,981 |
| | $ | 817,441 |
| Net fair value | $ | 4,796 |
| | $ | 3,494 |
|
|
Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet |
The following table represents the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments: | | | | | | | | | | Fair values of derivative instruments designated as hedging instruments | | Fair values of derivative instruments not designated as hedging instruments | | (in thousands) | Balance at July 31, 2020 | | | | Other current assets | $ | 7,103 |
| | $ | 60 |
| Accrued liabilities | $ | 2,268 |
| | $ | 100 |
| Balance at October 31, 2019 | | | | Other current assets | $ | 7,327 |
| | $ | 53 |
| Accrued liabilities | $ | 3,715 |
| | $ | 171 |
|
|
Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax |
The following table represents the unaudited condensed consolidated statements of operations location in Revenue/Deferred Revenue and Operating Expenses and amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax: | | | | | | | | | | | | | | Location of gain (loss) recognized in OCI on derivatives | | Amount of gain (loss) recognized in OCI on derivatives (effective portion) | | Location of gain (loss) reclassified from OCI | | Amount of gain (loss) reclassified from OCI (effective portion) | | (in thousands) | Three months ended July 31, 2020 | | | | | | | | Foreign exchange contracts | Revenue | | $ | 626 |
| | Revenue | | $ | 466 |
| Foreign exchange contracts | Operating expenses | | 11,773 |
| | Operating expenses | | (1,175 | ) | Total | | | $ | 12,399 |
| | | | $ | (709 | ) | Three months ended July 31, 2019 | | | | | | | | Foreign exchange contracts | Revenue | | $ | (994 | ) | | Revenue | | $ | 685 |
| Foreign exchange contracts | Operating expenses | | (76 | ) | | Operating expenses | | (3,945 | ) | Total | | | $ | (1,070 | ) | | | | $ | (3,260 | ) | Nine months ended July 31, 2020 | | | | | | | | Foreign exchange contracts | Revenue | | $ | 2,836 |
| | Revenue | | $ | 648 |
| Foreign exchange contracts | Operating expenses | | 1,129 |
| | Operating expenses | | (2,211 | ) | Total | | | $ | 3,965 |
| | | | $ | (1,563 | ) | Nine months ended July 31, 2019 | | | | | | | | Foreign exchange contracts | Revenue | | $ | (253 | ) | | Revenue | | $ | 1,048 |
| Foreign exchange contracts | Operating expenses | | 5,097 |
| | Operating expenses | | (12,795 | ) | Total | | | $ | 4,844 |
| | | | $ | (11,747 | ) |
|